Summary PlantForm Corp (PlantForm) is a biopharmaceutical company that develops and produces specialty antibody and protein drugs.The company’s pipeline products include biosimilar ranibizumab, trastuzumab, hD9 antibody for ricin exposure, recombinant butyrylcholinesterase, antibodies for HIV or AIDS and ebola virus.
Its recombinant butyrylcholinesterase is an enzyme that provides prophylactic protection against nerve agents.PlantForm utilizes vivoxpress technology platform to produce biologic large molecule drugs including monoclonal antibodies and therapeutic proteins.
It partners with other companies to develop additional targeted biosimilar and innovator drugs.The company operates through its offices located in Toronto and Sarnia in Canada; and California, the US.
PlantForm is headquartered in Guelph, Ontario, Canada.
PlantForm Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Macular Edema - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Pipeline Review, H1 2020, provides an overview of the Macular Edema (Ophthalmology) pipeline landscape. Macular edema is swelling or fluid retention in a specialized...
219 pages •
By Asia Market Information & Development Company
• Sep 2020
China’s demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
Biosimilar Monoclonal Antibodies Market Research Report by Drug Class (Abciximab, Adalimumab, Bevacizumab, Infliximab, and Rituximab), by Application (Diagnostic, Protein Purification, and Therapeutic) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Biosimilar Monoclonal Antibodies Market is expected...
The North America bioreactors market is expected to reach US$ 2,102.75 Mn by 2027 from US$ 1,188.50 Mn in 2019. The market is estimated to grow at a CAGR of 7.5% during 2020-2027.The bioreactorsmarketis growing primarily due to the increasing adoption of single-use bioreactors and rising demand of bioreactors by biopharmaceutical and biotechnology...
Pertussis (Whooping Cough) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pertussis - Pipeline Review, H1 2020, provides an overview of the Pertussis (Infectious Disease) pipeline landscape. Pertussis, also known as whooping cough, is a...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.